Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
CNY 18.4
(-0.38%)
CNY 18.4
(-0.38%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 60.46 Million CNY | 817.7% |
| 2022 | 70.12 Million CNY | 13.55% |
| 2021 | 61.76 Million CNY | 37.29% |
| 2020 | 44.98 Million CNY | -23.07% |
| 2019 | 58.47 Million CNY | 38.82% |
| 2018 | 42.12 Million CNY | 11.79% |
| 2017 | 37.67 Million CNY | -10.32% |
| 2016 | 42.01 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 21.88 Million CNY | -89.45% |
| 2024 Q2 | 208.34 Million CNY | 766.92% |
| 2024 Q1 | 24.03 Million CNY | -84.85% |
| 2023 Q3 | 23.71 Million CNY | 59.25% |
| 2023 Q1 | 20.73 Million CNY | 2.95% |
| 2023 FY | 643.58 Million CNY | 817.7% |
| 2023 Q2 | 14.89 Million CNY | -28.19% |
| 2023 Q4 | 158.64 Million CNY | 568.96% |
| 2022 Q3 | 15.99 Million CNY | 324.7% |
| 2022 FY | 70.12 Million CNY | 13.55% |
| 2022 Q4 | 20.14 Million CNY | 25.93% |
| 2022 Q2 | 3.76 Million CNY | -87.54% |
| 2022 Q1 | 30.22 Million CNY | 33.09% |
| 2021 Q4 | 22.7 Million CNY | 30.58% |
| 2021 Q3 | 17.38 Million CNY | 461.96% |
| 2021 Q1 | 18.57 Million CNY | 73.17% |
| 2021 Q2 | 3.09 Million CNY | -83.34% |
| 2021 FY | 61.76 Million CNY | 37.29% |
| 2020 Q2 | 9.88 Million CNY | -20.7% |
| 2020 FY | 44.98 Million CNY | -23.07% |
| 2020 Q4 | 10.72 Million CNY | -10.03% |
| 2020 Q3 | 11.92 Million CNY | 20.66% |
| 2020 Q1 | 12.45 Million CNY | -29.86% |
| 2019 Q3 | 17.76 Million CNY | 28.51% |
| 2019 FY | 58.47 Million CNY | 38.82% |
| 2019 Q4 | 17.76 Million CNY | 0.0% |
| 2019 Q2 | 13.82 Million CNY | 0.0% |
| 2019 Q1 | 13.82 Million CNY | 0.0% |
| 2018 FY | 42.12 Million CNY | 11.79% |
| 2017 FY | 37.67 Million CNY | -10.32% |
| 2016 FY | 42.01 Million CNY | 0.0% |